A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer’s disease

Published:2016-08-01 Issue:18 Volume:233 Page:3371-3381
ISSN:0033-3158
Container-title:Psychopharmacology
language:en
Short-container-title:Psychopharmacology

Author:

Reeves Suzanne,Bertrand Julie,D’Antonio Fabrizia,McLachlan Emma,Nair Akshay,Brownings Stuart,Greaves Suki,Smith Alan,Taylor David,Howard Robert

Funder

Research Trainees Coordinating Centre

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s00213-016-4379-6.pdf

Reference46 articles.

1. Akil A et al. (2016) A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer’s disease patients with agitation. J Pharmacokinet Pharmacodyn 43:99–109. doi: 10.1007/s10928-015-9457-6

2. Bergemann N, Kopitz J, Kress KR, Frick A (2004) Plasma amisulpride levels in schizophrenia or schizoaffective disorder. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 14:245–250. doi: 10.1016/j.euroneuro.2003.09.001

3. Bigos KL, Chew ML, Bies RR (2008a) Pharmacokinetics in geriatric psychiatry. Curr Psychiatry Rep 10:30–36

4. Bigos KL et al. (2008b) Sex, race, and smoking impact olanzapine exposure. J Clin Pharmacol 48:157–165

5. Bowskill SV, Patel MX, Handley SA, Flanagan RJ (2012) Plasma amisulpride in relation to prescribed dose, clozapine augmentation, and other factors: data from a therapeutic drug monitoring service, 2002-2010. Humanist Psychol 27:507–513. doi: 10.1002/hup.2256

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioequivalence of 200 mg Amisulpride Tablets in Healthy Chinese Volunteers under Fasting and Fed Conditions;Clinical Pharmacology in Drug Development;2023-11-20

2. Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer’s disease;PLOS ONE;2023-10-24

3. Population pharmacokinetics of Amisulpride in Chinese patients with schizophrenia with external validation: the impact of renal function;Frontiers in Pharmacology;2023-09-04

4. Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer’s disease;2023-05-16

5. A pharmacokinetic analysis of amisulpride in adult Chinese patients with schizophrenia: Impact of creatinine clearance;Int. Journal of Clinical Pharmacology and Therapeutics;2023-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3